As Allergan and AbbVie continue to move forward with their unification, a group of unions and consumer organizations have banded together in opposition to the $63 billion merger citing concerns that the business combination will create a monopoly and harm competition.

N.Y.-based NPXe filed a voluntary petition to reorganize under Chapter 11 of the Bankruptcy Code and is seeking permission to auction off the company’s assets.

Bausch Health Companies Inc. was selected as the successful bidder to acquire certain assets of Synergy Pharmaceuticals Inc. for a cash purchase price of approximately $195 million and the assumption of certain assumed liabilities, pursuant to the terms of the stalking horse asset purchase agreement previously entered into.

Enumeral Biomedical filed for bankruptcy protection and is selling its assets to Xoma Corporation for $1.6 million.

Investors and business analysts are looking for Valeant Pharmaceuticals to begin unloading some of its assets, but the big question is which ones are up for sale?